About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

In a remarkable demonstration of medical expertise, CMRI Kolkata has successfully performed a highly intricate surgery on a patient of 72 years with a history of pancreatic cancer and hernia. | One of ...

Srinagar- The Bone and Joint (B&J) Hospital in Srinagar, the only tertiary care centre for orthopaedic treatment in the ...

Evelyn Carrera claimed to her family she was raped by one of the nurses at Mendoza Medical Center while recovering from a ...

The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...

Our outstanding team at Mission Hospital continues to raise the bar in providing exceptional care to our patients,” said Greg Lowe, chief executive officer of Mission Hospital and Mission Health.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...

Cincinnati Children's has named Daniel Ostlie, MD, as the health system's next surgeon in chief and senior vice president. Dr ...

Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, today announced that Unio Specialty Care, a rapidly growing physician ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...